Overview

Metabolic Effects of Hydroxychloroquine

Status:
Suspended
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The basic plan of the study is to randomize otherwise healthy subjects with type 2 diabetes to hydroxychloroquine, 200 mg twice daily or placebo.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Hydroxychloroquine